In the era of molecular imaging, in vivo 1 H magnetic resonance spectroscopy (MRS) and spectroscopic imaging (MRSI) are impacting dramatically upon virtually all areas of clinical medicine. MRS and MRSI should be able to identify key biochemical changes, much before the tumour becomes detectable by
Clinical applications in molecular imaging
β Scribed by Carola Heneweer; Jan Grimm
- Publisher
- Springer-Verlag
- Year
- 2010
- Tongue
- English
- Weight
- 541 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0301-0449
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract With the emergence of the new field of molecular imaging, there is an increasing demand for development of sensitive and safe novel imaging agents that can be rapidly translated from small animal models into patients. Nuclear medicine and positron emission tomography (PET) techniques ha
## Abstract Directionallyβordered cellular structures that impede water motion, such as cell membranes and myelin, result in water mobility that is also directionallyβdependent. Diffusion tensor imaging characterizes this directional nature of water motion and thereby provides structural informatio
Molecular imaging can reveal in vivo analysis and quantification of biochemical reactions. To enable cell-surface imaging of receptors, novel ligands have been developed which can be radiolabeled or imaged by bioluminescence. Specific examples include somatostatin receptors, estrogen and progesteron